Comfortable leader
16 companies value 64 bn revenue 43 bn margin 6.3% free cash flow 2.3 bn avg. score 1.7
GEHC holds 49.1% of the group's value, 1.3x the runner-up
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GEHC | GE HealthCare United States · score 5.6 | 49% | 32 bn | 21 bn | 9.3% | 1.5 bn | 4.6% | 0.2% | Medical imaging, ultrasound and patient monitoring equipment · Global leader in CT, MRI and ultrasound; a huge installed base | |
| 2 | PHG | Philips Netherlands · score 5.1 | 38% | 25 bn | 20 bn | 5.0% | 1.0 bn | 4.1% | 1.5% | Medical imaging and patient monitoring equipment, from the Netherlands · Medical imaging and hospital monitoring, with strong service revenue | |
| 3 | IRTC | iRhythm Holdings, Inc. United States · score 2.1 | 6% | 3.6 bn | 0.8 bn | -1.7% | 0.0 bn | 1.1% | — | Digital health for detecting and preventing arrhythmias · California — revenue of $825m | |
| 4 | BFLY | Butterfly Network, Inc. United States · score 0.0 | 3% | 2.0 bn | 0.1 bn | -66.7% | -0.0 bn | -1.4% | — | Handheld ultrasound with a silicon chip transducer · Massachusetts — revenue of $112m | |
| 5 | IRMD | IRADIMED CORP United States · score 6.1 | 2% | 1.1 bn | 0.1 bn | 26.7% | 0.0 bn | 2.2% | 1.4% | MRI-compatible medical devices · Florida — revenue of $86m | |
| 6 | VREX | Varex Imaging Corp United States · score 1.9 | 1% | 0.8 bn | 0.9 bn | 2.6% | -0.0 bn | -2.6% | — | X-ray imaging components: tubes, detectors and accelerators · Utah — revenue of $865m | |
| 7 | CV | CapsoVision, Inc United States · score 0.0 | 1% | 0.3 bn | 0.0 bn | -214.7% | -0.0 bn | -8.4% | — | Medical technology for gastrointestinal tract diagnostics · California — revenue of $14m | |
| 8 | HYPR | Hyperfine, Inc. United States · score 0.0 | 0% | 0.1 bn | 0.0 bn | -210.8% | -0.0 bn | -33.4% | — | Portable low-field MRI with AI · Connecticut — revenue of $17m | |
| 9 | QTI | QT IMAGING HOLDINGS, INC. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -77.3% | -0.0 bn | -37.4% | — | 3D breast imaging without ionizing radiation or compression · California — revenue of $26m | |
| 10 | AMS | AMERICAN SHARED HOSPITAL SERVICES United States · score 3.2 | 0% | 0.0 bn | 0.0 bn | -5.8% | 0.0 bn | 42.1% | — | Stereotactic radiosurgery equipment for hospitals · California — revenue of $30m | |
| 11 | MDAI | Spectral AI, Inc. United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -65.5% | -0.0 bn | -26.3% | — | AI for predictive medical diagnostics · Texas — revenue of $15m | |
| 12 | NNOX | Nano-X Imaging Ltd. Israel · score 0.0 | 0% | 0.0 bn | 0.0 bn | -747.2% | -0.1 bn | -161.8% | — | Digital X-ray tubes and imaging systems, from Israel · Israel — revenue of $16m | |
| 13 | PLSM | Pulsenmore Ltd. Israel · score 0.0 | 0% | 0.0 bn | 0.0 bn | -39.6% | -0.0 bn | — | -89.2% | — | Home ultrasound for pregnant women, from Israel · Israel — revenue of $13m |
| 14 | BEAT | HeartBeam, Inc. United States · score 0.0 | 0% | 0.0 bn | — | — | -0.0 bn | -60.1% | — | Medical technology for personalized cardiac monitoring · California | |
| 15 | NDRA | ENDRA Life Sciences Inc. United States · score 0.0 | 0% | 0.0 bn | — | — | 0.0 bn | -68.2% | — | Thermoacoustic ultrasound for diagnostic imaging · Michigan | |
| 16 | MBAI | MBody AI Ltd. Israel · score 3.7 | — | — | — | — | 0.0 bn | — | — | Prep-free colon imaging capsule, from Israel · Israel |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
and 22 industries more
- Molecular testing and advanced diagnostics 42 companies
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.